en

PRODUCT DETAIL

Maviret 100 mg/40 mg filmom obalené tablety

Code 4819C
MA number EU/1/17/1213/001
Product Form: tbl flm 84 (4x21)x100 mg/40 mg (blis.PVC/PE/PCTFE/Al)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 42 - CHEMOTHERAPEUTICA (VRATANE TUBERKULOSTATIK)
ATC:
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AP ?
J05AP57 Glecaprevir and pibrentasvir
Shelf life: 36
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 26.07.2017
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 28.03.2022
eu-flag.png sk-flag.png